FDA approves Regeneron's COVID-19 emergency treatment | WNYT.com

FDA approves Regeneron's COVID-19 emergency treatment

WNYT Staff
Created: November 22, 2020 07:46 AM

The U.S. Food and Drug Administration has given the green light for emergency authorization for a coronavirus antibody treatment.

The therapy was developed by Regeneron, which has a facility in Rensselaer.

This cocktail is the same one given to President Trump when he contracted COVID-19 in October.

Regeneron submitted an emergency use application after pre-clinical studies showed the therapy reduced the amount of the virus and associated damage in the lungs of non-human primates.

Copyright 2020 - WNYT-TV, LLC A Hubbard Broadcasting Company

Comment on Facebook
Primary elections underway in New York state

Valatie community looks to address 'problem' intersection

People can fish for free in NY state this weekend

PHOTOS: Severe storms hit Capital Region

Car crashes into Schodack garage